| Fluad |
influenza vaccine (surface antigen, inactivated, adjuvanted) | | J07BB02 | | Seqirus Netherlands B.V. | Opinion |
| Flucelvax |
influenza vaccine (surface antigen, inactivated, prepared in cell cultures) | | J07BB02 | 2024-11-15 | Seqirus Netherlands B.V. | Authorised |
| Flucelvax Tetra |
influenza vaccine (surface antigen, inactivated, prepared in cell cultures) | | J07BB02 | 2018-12-12 | Seqirus Netherlands B.V. | Authorised |
| Fluenz Tetra |
influenza vaccine (live attenuated, nasal) | | J07BB03 | 2013-12-04 | AstraZeneca AB | Authorised |
| Pandemic Influenza Vaccine H5N1 Baxter AG |
pandemic influenza vaccine (H5N1) (whole virion, inactivated, prepared in cell culture) | | J07BB01 | 2009-10-16 | Resilience Biomanufacturing Ireland Limited | Withdrawn |
| Fluad Tetra |
influenza vaccine (surface antigen, inactivated, adjuvanted) | | J07BB02 | 2020-05-20 | Seqirus Netherlands B.V. | Authorised |
| Pandemic influenza vaccine H5N1 AstraZeneca (previously Pandemic influenza vaccine H5N1 Medimmune) |
pandemic influenza vaccine (H5N1) (live attenuated, nasal) | | J07BB03 | 2016-05-20 | AstraZeneca AB | Authorised |
| Aflunov |
zoonotic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) | H5N1流感疫苗 | J07BB02 | 2010-11-28 | Seqirus S.r.l. | Authorised |
| Supemtek |
Quadrivalent influenza vaccine (recombinant, prepared in cell culture) | | J07BB02 | 2020-11-16 | Sanofi Pasteur | Authorised |
| Adjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals) |
pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) | H5N1流感疫苗 | J07BB02 | 2009-10-10 | GlaxoSmithKline Biologicals S.A. | Authorised |
| Foclivia |
pandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) | H5N1流感疫苗 | J07BB02 | 2009-10-18 | Seqirus S.r.l. | Authorised |
| Prepandrix |
prepandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) | H5N1流感疫苗 | J07BB02 | 2008-05-14 | GlaxoSmithKline Biologicals S.A. | Withdrawn |
| Vepacel |
Prepandemic influenza vaccine (H5N1) (whole virion, inactivated,prepared in cell culture) | H5N1流感疫苗 | J07BB01 | 2012-02-17 | Ology Bioservices Ireland LTD | Withdrawn |
| Intanza |
influenza vaccine (split virion, inactivated) | | J07BB02 | 2009-02-24 | Sanofi Pasteur Europe | Withdrawn |
| IDflu |
influenza vaccine (split virion, inactivated) | | J07BB02 | 2009-02-24 | Sanofi Pasteur S.A. | Withdrawn |
| Optaflu |
influenza vaccine (surface antigen, inactivated, prepared in cell cultures) | | J07BB02 | 2007-06-01 | Seqirus GmbH | Expired |
| Celvapan |
influenza vaccine (H1N1)v (whole virion, Vero cell derived, inactivated) | | J07BB01 | 2009-03-04 | Nanotherapeutics Bohumil, s.r.o. | Withdrawn |
| Pandemrix |
influenza vaccine (H1N1)v (split virion, inactivated, adjuvanted) | | J07BB02 | 2008-05-20 | GlaxoSmithKline Biologicals S.A. | Expired |
| Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) Novartis Vaccines and Diagnostics |
prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) | | J07BB02 | 2010-11-29 | Novartis Vaccines and Diagnostics S.r.l. | Expired |
| Focetria |
influenza vaccine H1N1v (surface antigen, inactivated, adjuvanted) | | J07BB02 | 2007-05-02 | Novartis Vaccines and Diagnostics S.r.l. | Expired |
